The Synthetic Biology Innovation Network

Editors' picks

Why synthetic biology investors need to look beyond Silicon Valley and Boston

Synthetic biology, the field concerned with the design and construction of novel biological systems, has received intense interest from both startup investors and the broader media. The amount of investment in the area...

Institute of Systems and Synthetic Biology

The five hottest synthetic biology job markets in the world

The top 10 skills synthetic biologists will need for 2019

Synthetic biology is one of the most rapidly advancing fields in the world today. From universal vaccine development and CRISPR-Cas9 applications to agritech and biofuels, synthetic biology is establishing itself as a...

In synthetic biology, it’s not only what you measure, but how you share it.

Synthetic biology and reproducibility meet on the Internet (of Things)

Measuring what matters: A Q&A with Agilent’s Darlene Solomon

In our quest to make biology easier to engineer, one thing that continues to be of utmost importance is our ability to measure biology accurately. The Internet of Things (IoT) and advanced hardware platform systems are...

New cell-free expression system runs on linear DNA

How sweet it is: The next generation of natural, zero-calorie sweeteners

The past decades have seen a sharp rise in obesity, diabetes, and Metabolic syndrome, especially among younger and younger children. Experts and non-experts alike are attributing this trend to the sugar in our diets...

The future of DNA synthesis

These 98 synthetic biology companies raised $3.8 billion in 2018

View all posts

Press releases

Genomatica Produces The First 600 Tons of Brontide Natural Butylene Glycol

Daicel, Azelis, Viachem equipped to service rising demand from hundreds of personal care formulators San Diego, California (January 15, 2019) – Genomatica, a widely-recognized technology leader for bio-based chemicals...

Arbor Biosciences and the IWGSC Partner on Wheat Exome

Arbor Biosciences, a worldwide leader in next generation sequencing (NGS) target enrichment and synthetic biology, announces their partnership with the International Wheat Genome Sequencing Consortium (IWGSC), an...

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

NEWS – Bournemouth, UK – 14th January 2019: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This...

Inovio’s DNA-Encoded Monoclonal Antibody (dMAb™) Platform Leaps Forward with First-in-Human Trial

PLYMOUTH MEETING, Pa., Jan. 7, 2019 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) in collaboration with The Wistar Institute and the University of Pennsylvania announced today the initiation of the...

AbSci Establishes New Collaboration with Sanofi

AbSci and Sanofi entered into a collaboration to improve the manufacturability for two of Sanofi’s biotherapeutics VANCOUVER, Wash., Jan. 9, 2019 /PRNewswire/ — AbSci, a global leader in biotherapeutic...

Asimov Appoints Synthetic Biology Pioneer James J. Collins as Inaugural Member of Scientific Advisory Board

Dr. Collins brings multi-disciplinary expertise in the design and construction of synthetic gene circuits and programmable cells Cambridge, MA – January 11, 2019. Asimov, the synthetic biology company building a...

GreenLight Biosciences Announces $50 Million Funding Round

– Unique Cell-Free Bioproduction Platform delivers cost effective, high quality RNA solutions to human, animal and crop challenges. – Round will fund the expansion of discovery, development and commercial...

Sigilon Therapeutics and MIT Announce Research Collaboration to Advance Programmable Living Therapeutics for Serious Chronic Diseases

CAMBRIDGE, Mass. — January 7, 2019 — Sigilon Therapeutics, a biopharmaceutical company that discovers and develops Shielded Living Therapeutics, and the Massachusetts Institute of Technology today announced a strategic...

Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

January 07, 2019 08:00 AM Eastern Standard Time – SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality...

Vertex and Arbor Biotechnologies Establish Collaboration to Discover Novel Proteins to Advance Discovery of Gene-Editing Therapies

-Multi-year research collaboration funded by Vertex using Arbor’s proprietary research platform to enhance efforts in developing gene-editing therapies in five diseases- -Arbor to receive up-front cash payment and...

AmpliPhi Biosciences and C3J Therapeutics Agree to Merge

Transaction to result in NYSE American-listed company focused on development of precisely-targeted bacteriophage therapeutics Merger combines AmpliPhi’s extensive phage library and Phase 1/2-ready asset with C3J’s...

Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines

SEATTLE, Jan. 4, 2019 /PRNewswire/ — Sana Biotechnology, Inc. (Sana), a new company focused on creating and delivering engineered cells as medicines for patients, announced its launch today. Recent scientific...

The Synthetic Biology Innovation Network

Editors' picks

Why synthetic biology investors need to look beyond Silicon Valley and Boston

The five hottest synthetic biology job markets in the world

The top 10 skills synthetic biologists will need for 2019

In synthetic biology, it’s not only what you measure, but how you share it.

Synthetic biology and reproducibility meet on the Internet (of Things)

Measuring what matters: A Q&A with Agilent’s Darlene Solomon

New cell-free expression system runs on linear DNA

How sweet it is: The next generation of natural, zero-calorie sweeteners

The future of DNA synthesis

These 98 synthetic biology companies raised $3.8 billion in 2018

Press releases

Genomatica Produces The First 600 Tons of Brontide Natural Butylene Glycol

Arbor Biosciences and the IWGSC Partner on Wheat Exome

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Inovio’s DNA-Encoded Monoclonal Antibody (dMAb™) Platform Leaps Forward with First-in-Human Trial

AbSci Establishes New Collaboration with Sanofi

Asimov Appoints Synthetic Biology Pioneer James J. Collins as Inaugural Member of Scientific Advisory Board

GreenLight Biosciences Announces $50 Million Funding Round

Sigilon Therapeutics and MIT Announce Research Collaboration to Advance Programmable Living Therapeutics for Serious Chronic Diseases

Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

Vertex and Arbor Biotechnologies Establish Collaboration to Discover Novel Proteins to Advance Discovery of Gene-Editing Therapies

AmpliPhi Biosciences and C3J Therapeutics Agree to Merge

Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines

News by topic

Agriculture

Health and medicine

Funding & investments

Biomanufacturing, chemicals & materials

Emerging technologies

Food and nutrition

Consumer goods

Energy & environment

Policy & public

Entrepreneurship

What do you like about our website and what can we improve?

Give feedback